PhD student in host-pathogen interaction / drug discovery (100%) - Swiss TPH
The Swiss Tropical and Public Health Institute (Swiss TPH) is a world-leading institute in global health with a particular focus on low- and middle-income countries. Associated with the University of Basel, Swiss TPH combines research, education and services at local, national and international levels. 950 people from 95 nations work at Swiss TPH focusing on infectious and non-communicable diseases, environment, society and health as well as health systems and interventions.
The Department of Medical Parasitology and Infection Biology (MPI) investigates the biology and transmission of pathogens. Findings from this research inform the development of new diagnostics, treatments, and vaccines against malaria, tuberculosis, schistosomiasis, Chagas and other neglected tropical diseases.
Within the Parasite Chemotherapy Unit of MPI, we are looking for a
PhD student in host-pathogen interaction / drug discovery (100%)
We are seeking a PhD student for the research project "iPS technology to decipher leishmaniasis". This project is funded by the Walter-Fischli-Foundation. The successful applicant will be based at the Swiss TPH and registered for a PhD degree at the University of Basel, Switzerland. The anticipated start is in Fall 2024.
How to apply:
Please submit your application online.
- CV
- Motivational letter including names and contact information (email or phone number) of 1 – 2 references
- Reference letters and diploma
Together, we can make the world a healthier place. We look forward to receiving your application.
Please note that we can only accept applications via our online recruiting tool. Applications via email or external recruiter will not be considered.
The closing date for application is 30th September 2024.
Contact:
To get more information about the position, please contact:
Pascal Mäser, Write an email
CH-4051 Basel / Basel / Allschwil
